SV
Shashikant Vitthal Beloshe
About Shashikant Vitthal Beloshe
Data last updated:
Shashikant Vitthal Beloshe is a Director at Investbell Nidhi Limited (since 2021) and Designated Partner at Kenzion Pharmaceuticals Llp (since 2023). The companies operate in Financial Services and Business Services. The largest current company by reported revenue is Investbell Nidhi Limited at ₹58.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Investbell Nidhi Limited U65990MH2021PLN354047 | Director | 23 Jan 2021 | 2021 | ₹58.3 Lakh (FY 2025) | Active |
| Kenzion Pharmaceuticals Llp ACB-3938 | Designated Partner | 29 May 2023 | 2023 | Active |
Board colleagues of Shashikant Vitthal Beloshe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shankar Baban Dhanawade | 09041569 | Investbell Nidhi Limited , Kenzion Pharmaceuticals Llp | Director |
| Tanaji Vitthal Beloshe | 09041571 | Investbell Nidhi Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shashikant Vitthal Beloshe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shashikant Vitthal Beloshe
Shashikant Vitthal Beloshe currently holds 2 directorships: Investbell Nidhi Limited (Director, since 23 Jan 2021, revenue ₹58.3 Lakh (FY 2025)); Kenzion Pharmaceuticals Llp (Designated Partner, since 29 May 2023).
Shashikant Vitthal Beloshe was first appointed on 23 Jan 2021 as Director at Investbell Nidhi Limited. The most recent appointment on record is 29 May 2023 at Kenzion Pharmaceuticals Llp.
The current boards of Shashikant Vitthal Beloshe's companies include Shankar Baban Dhanawade (Investbell Nidhi Limited), Tanaji Vitthal Beloshe (Investbell Nidhi Limited).